Paul Chang Lee

Array ( [id] => 14418859 [patent_doc_number] => RE047428 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-06-11 [patent_title] => Modulators of methyl modifying enzymes, compositions and uses thereof [patent_app_type] => reissue [patent_app_number] => 15/878663 [patent_app_country] => US [patent_app_date] => 2018-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 1 [patent_no_of_words] => 21045 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14451337 [patent_doc_number] => RE047437 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-06-18 [patent_title] => Prolyl hydroxylase inhibitors and methods of use [patent_app_type] => reissue [patent_app_number] => 15/875495 [patent_app_country] => US [patent_app_date] => 2018-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20865 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13566223 [patent_doc_number] => 20180334659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-22 [patent_title] => XYLANASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM [patent_app_type] => utility [patent_app_number] => 15/831357 [patent_app_country] => US [patent_app_date] => 2017-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15831357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17525083 [patent_doc_number] => RE049026 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-04-12 [patent_title] => Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof [patent_app_type] => reissue [patent_app_number] => 15/727360 [patent_app_country] => US [patent_app_date] => 2017-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 36542 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15727360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16381241 [patent_doc_number] => RE048267 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2020-10-20 [patent_title] => Variants of C-type natriuretic peptide [patent_app_type] => reissue [patent_app_number] => 15/646822 [patent_app_country] => US [patent_app_date] => 2017-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 84 [patent_no_of_words] => 63989 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15646822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13884067 [patent_doc_number] => RE047222 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-02-05 [patent_title] => Peptide sequences and compositions [patent_app_type] => reissue [patent_app_number] => 15/469016 [patent_app_country] => US [patent_app_date] => 2017-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 15598 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13048175 [patent_doc_number] => RE046990 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-08-14 [patent_title] => Anti-inflammatory agents [patent_app_type] => reissue [patent_app_number] => 15/449623 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 16398 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13275699 [patent_doc_number] => RE047153 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-12-11 [patent_title] => Genipin-rich material and its use [patent_app_type] => reissue [patent_app_number] => 15/438079 [patent_app_country] => US [patent_app_date] => 2017-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4720 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15438079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13286883 [patent_doc_number] => RE047164 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-12-18 [patent_title] => None [patent_app_type] => reissue [patent_app_number] => 15/388122 [patent_app_country] => US [patent_app_date] => 2016-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 29 [patent_no_of_words] => 14601 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15388122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16490440 [patent_doc_number] => RE048345 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2020-12-08 [patent_title] => Compositions and methods for inhibiting gene expression of hepatitis B virus [patent_app_type] => reissue [patent_app_number] => 15/241733 [patent_app_country] => US [patent_app_date] => 2016-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 15053 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15241733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14451341 [patent_doc_number] => RE047439 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-06-18 [patent_title] => Method for manufacture of macrobeads [patent_app_type] => reissue [patent_app_number] => 15/226341 [patent_app_country] => US [patent_app_date] => 2016-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 5332 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15226341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12423126 [patent_doc_number] => RE046860 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-05-22 [patent_title] => Recombinant cell clones having increased stability and methods of making and using the same [patent_app_type] => reissue [patent_app_number] => 15/203558 [patent_app_country] => US [patent_app_date] => 2016-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6515 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15203558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12505170 [patent_doc_number] => RE046897 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-06-19 [patent_title] => Recombinant cell clones having increased stability and methods of making and using the same [patent_app_type] => reissue [patent_app_number] => 15/203550 [patent_app_country] => US [patent_app_date] => 2016-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6513 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15203550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12362268 [patent_doc_number] => RE046815 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-05-01 [patent_title] => Furanone derivative [patent_app_type] => reissue [patent_app_number] => 15/172021 [patent_app_country] => US [patent_app_date] => 2016-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49377 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15172021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12321111 [patent_doc_number] => RE046788 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-04-17 [patent_title] => Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production [patent_app_type] => reissue [patent_app_number] => 15/161134 [patent_app_country] => US [patent_app_date] => 2016-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12087 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15161134 [rel_patent_id] =>[rel_patent_doc_number] =>)